LICENSE AGREEMENTLicense Agreement • January 16th, 2018 • resTORbio, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledJanuary 16th, 2018 Company Industry JurisdictionThis License Agreement (“Agreement”), made as of March 23, 2017 (“Effective Date”), is by and between Novartis International Pharmaceutical Ltd., a for-profit corporation with its principal place of business at Lichtstrasse 35, CH-4056 Basel, Switzerland (“Novartis”) and resTORbio, Inc., a Delaware corporation located at 501 Boylston Street, Suite 6102, Boston, Massachusetts 02116 (“resTORbio”). Novartis and resTORbio are each referred to individually as a “Party” and together as the “Parties.”
LICENSE AGREEMENTLicense Agreement • December 1st, 2017 • resTORbio, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledDecember 1st, 2017 Company Industry JurisdictionThis License Agreement (“Agreement”), made as of March 23, 2017 (“Effective Date”), is by and between Novartis International Pharmaceutical Ltd., a for-profit corporation with its principal place of business at Lichtstrasse 35, CH-4056 Basel, Switzerland (“Novartis”) and resTORbio, Inc., a Delaware corporation located at 501 Boylston Street, Suite 6102, Boston, Massachusetts 02116 (“resTORbio”). Novartis and resTORbio are each referred to individually as a “Party” and together as the “Parties.”